Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)

BioIPSeeds Trusted Platform

BioIPSeeds creates a new model for academia-industry interaction by providing an effective, safe and trustful environment.

TRPMA visited the incoming Vice President

Mr Ho led TRPMA representatives to visit Dr Chen Chien-Jen to congratulate his election to next Vice President of Taiwan. The group delivered the industry’s suggestions, hoping to accelerate the industry’s development.

The 5th Cross-strait Biotech Communication Conference

Taiwan: TRPMA and DTCO Jointly Announce the Development of “TRPMA Biopharma Trusted Platform”

Taiwan: TRPMA and DTCO Jointly Announce the Development of “TRPMA Biopharma Trusted Platform”

(Source: TRPMA 2016-05-10）

Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA) announced the collaboration with Digital Treasury Corporation (DTCO) to jointly develop the “TRPMA Biopharma Trusted Platform”, an application of the latest Blockchain Technology.

Read More

Welcome to TRPMA website

Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), composed of 28 Taiwanese innovative biopharmaceutical companies, plays a pivotal role in coordinating the resources, strengthening alliances among the industry, the academic and the government in Taiwan. TRPMA members aim to create a competitive value chain of biopharmaceutical industry to boost the nation's economy and promote the Asian and global cooperation in biopharmaceutical innovation.

Industry News

UK: Scotland to house world-first manufacturing innovation centre

A £56-million drug manufacturing innovation centre - the first of its kind in the world - has been announced for Renfrewshire in Scotland.

Read More
EU: Guidance for pharmaceutical companies to prepare for UK’s withdrawal from EU

The European Medicines Agency (EMA) and the European Commission have updated their guidance to help pharmaceutical companies prepare for the United Kingdom’s (UK) withdrawal from the European Union (EU).

Read More
US: FDA to begin updating generic cancer drug labels with new congressional funding

The US Food and Drug Administration (FDA) on Monday announced it would use new budget funding to update generic drug labels and will begin with cancer drugs, among other initiatives.

Read More